Literature DB >> 17414437

Cutaneous malignant ossifying fibromyxoid tumor.

Thomas L Cibull1, Steven D Billings.   

Abstract

A 76-year-old woman presented with a well-circumscribed 3 cm mass of her right buttock. The tumor, partially surrounded by a shell of woven and lamellar bone, had a lobular arrangement of highly cellular islands of tumor cells embedded in a variably fibrous to myxoid stroma. The lesional cells had well defined cytoplasmic membranes with varying amounts of clear to lightly eosinophilic cytoplasm. The nuclei exhibited moderate to severe nuclear atypia. Areas of tumor necrosis were present. The mitotic rate was 17 MF/50 high-power fields. The tumor was diagnosed as an ossifying fibromyxoid tumor (OFMT). OFMT is a rare tumor first described in 1989. Although OFMT usually occurs in deep soft tissue, up to 11% of reported lesions presented as cutaneous tumors. OFMT usually present in adults on the extremities or trunk. Most are histologically bland and apparently benign tumors, but OFMT with high nuclear grade, high cellularity, and >2 MF/50 high-power fields have shown potential for aggressive behavior including metastasis. OFMT with these features should be considered sarcomas. Given the histologic features, this tumor was considered a malignant OFMT. The patient had a wide excision. The patient died secondary to unrelated comorbidities without evidence of recurrence or metastasis.

Entities:  

Mesh:

Year:  2007        PMID: 17414437     DOI: 10.1097/01.dad.0000211530.26047.2b

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Malignant ossifying fibromyxoid tumor of the calvaria: illustrative case.

Authors:  Jan T Hachmann; R Scott Graham
Journal:  J Neurosurg Case Lessons       Date:  2021-08-23

2.  Ossifying fibromyxoid tumor of soft tissue: A case report with review of literature.

Authors:  Ahlem Bchir; Ahlem Bellalah; Nouha Ben Abdeljelil; Manel Njima; Leila Njim; Abdelfateh Zakhama; Rym Hadhri
Journal:  Ann Med Surg (Lond)       Date:  2021-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.